Effect of the extract of ivy leaves on the production of antimicrobial peptides in acute simple bronchitis in children
Journal Title: Здоров`я дитини - Year 2018, Vol 13, Issue 6
Abstract
Background. Currently, there is a tendency to a chronicity of acute respiratory infections, which requires the development of medications to prevent its development. The purpose of the work was to study the clinical and immunological efficacy of the extract of ivy leaves in the treatment of acute simple bronchitis in children. Materials and methods. We have examined 40 children aged 2 to 6 years with acute simple bronchitis, 14 patients received Pectolvan Hedera. During the work, clinical and laboratory methods of investigation were used. The severity of the patient’s condition was assessed according to the Bronchitis severity score. The laboratory study included: general blood and urine test, the use of nasocytological, immunoassay methods. The etiological diagnosis was established on the basis of virological methods of investigation. When determining lactoferrin concentration, Human Lactoferrin HK329 Edition 06-16 set manufactured by Hycult Biotech (USA) was used, neutrophilic α-defensin (1–3) content — Human HNP HK317 Edition 08-16 reagents manufactured by Hycult Biotech (USA). Results. Acute bronchitis in the examined patients is caused by viral agents. In all children with acute simple bronchitis, the disease began acutely and manifested itself with catarrhal and general inflammatory syndromes. The use of Pectolvan Hedera expectorant in the therapy helped to reduce the clinical manifestations of the disease more rapidly, to prevent chronicity, was accompanied by a significant decrease in the number of leukocytes in the nasal mucosa and an increase in the lactoferrin content in the oropharyngeal secretions until the period of convalescence. Conclusions. Extract of ivy leaves is not only a symptomatic expectorant, but also a pathogenetic drug that can be considered a drug of choice in the treatment of acute simple bronchitis in children.
Authors and Affiliations
A. E. Abaturov, N. M. Tokareva, A. A. Nikulina
Keywords
Related Articles
- EP ID EP393094
- DOI 10.22141/2224-0551.13.6.2018.143157
- Views 80
- Downloads 0
Therapy in Bronchopulmonary Diseases Associated with Increased Secretion of Viscous Sputum and Impaired Mucus Transport
The article deals with the problem of cough in bronchopulmonary diseases, in particular, the attention is paid to cough with increased secretion of viscous sputum, i.e., productive cough. It is noticed that derivative of...
Dear readears, colleagues!
.
Bacterial Lysates as a Key Drug Component of the Prevention and Treatment for Acute Respiratory Infections in Children
The article describes the possibilities of the control of innate and adaptive immunity by medications, in particular through the use of bacterial lysate Broncho-munal®. Immunoregulatory role of bacterial lysates is prese...
Differentiated Approach to the Mucolytic Therapy for Respiratory Diseases in Children
This paper presents the mechanisms of disorders of mucociliary clearance in the tracheobronchial tree in respiratory diseases in children. The authors considered differentiated approach to the prescription of mucoactive...
Experience of Using Ursodeoxycholic Acid in Children with Organic Diseases of the Liver
The mechanisms of ursodeoxycholic acid effects on the human body, the findings of clinical studies and observations on the use of ursodeoxycholic acid preparation for the treatment of children with organic diseases of th...